Lip GYH - Search Results

1

A review of risk factors for retinal vein occlusions.

Ørskov M, Vorum H, Bjerregaard Larsen T, Vestergaard N, Lip GYH, Bek T, Skjøth F. Ørskov M, et al. Among authors: lip gyh. Expert Rev Cardiovasc Ther. 2022 Sep;20(9):761-772. doi: 10.1080/14779072.2022.2112667. Epub 2022 Aug 19. Expert Rev Cardiovasc Ther. 2022. PMID: 35972726 Review.

2

Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy.

Kakar P, Lip GY. Kakar P, et al. Expert Rev Cardiovasc Ther. 2007 May;5(3):441-50. doi: 10.1586/14779072.5.3.441. Expert Rev Cardiovasc Ther. 2007. PMID: 17489669 Review.

3

Assessment of endothelial dysfunction.

Freestone B, Krishnamoorthy S, Lip GY. Freestone B, et al. Expert Rev Cardiovasc Ther. 2010 Apr;8(4):557-71. doi: 10.1586/erc.09.184. Expert Rev Cardiovasc Ther. 2010. PMID: 20397829 Review.

4

Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study.

Larsen TB, Lip GY, Skjøth F, Due KM, Overvad K, Hvilsted Rasmussen L. Larsen TB, et al. Circ Cardiovasc Qual Outcomes. 2012 May;5(3):335-42. doi: 10.1161/CIRCOUTCOMES.111.964023. Epub 2012 Apr 24. Circ Cardiovasc Qual Outcomes. 2012. PMID: 22534406

5

Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.

Lip GY, Larsen TB, Skjøth F, Rasmussen LH. Lip GY, et al. J Am Coll Cardiol. 2012 Aug 21;60(8):738-46. doi: 10.1016/j.jacc.2012.03.019. Epub 2012 May 9. J Am Coll Cardiol. 2012. PMID: 22575324 Free article.

6

Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study.

Lip GY, Rasmussen LH, Skjøth F, Overvad K, Larsen TB. Lip GY, et al. BMJ Open. 2012 Jul 7;2(4):e000975. doi: 10.1136/bmjopen-2012-000975. Print 2012. BMJ Open. 2012. PMID: 22773537 Free PMC article.

7

Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis.

Rasmussen LH, Larsen TB, Graungaard T, Skjøth F, Lip GY. Rasmussen LH, et al. BMJ. 2012 Nov 5;345:e7097. doi: 10.1136/bmj.e7097. BMJ. 2012. PMID: 23129490 Free PMC article.

8

New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation.

Ahmad Y, Lip GY, Apostolakis S. Ahmad Y, et al. Expert Rev Cardiovasc Ther. 2012 Dec;10(12):1471-80. doi: 10.1586/erc.12.148. Expert Rev Cardiovasc Ther. 2012. PMID: 23253272 Review.

9

Reply: To PMID 22575324.

Lip GY, Larsen TB, Skjøth F, Rasmussen LH. Lip GY, et al. J Am Coll Cardiol. 2013 Feb 5;61(5):596. doi: 10.1016/j.jacc.2012.10.034. Epub 2012 Dec 26. J Am Coll Cardiol. 2013. PMID: 23273397 Free article. No abstract available.

10

Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.

Larsen TB, Rasmussen LH, Skjøth F, Due KM, Callréus T, Rosenzweig M, Lip GY. Larsen TB, et al. J Am Coll Cardiol. 2013 Jun 4;61(22):2264-73. doi: 10.1016/j.jacc.2013.03.020. Epub 2013 Apr 3. J Am Coll Cardiol. 2013. PMID: 23562920 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,447 results

Search Page